IOBT icon

IO Biotech

19 hedge funds and large institutions have $30.6M invested in IO Biotech in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
3
Reduced
4
Closed
1
Calls
$1.16M
Puts
Net Calls
+$1.16M
Net Calls Change
-$553K
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$7.22M 6,173,439
NHAS
2
Novo Holdings A/S
Denmark
$5.18M 4,429,449 -658,809 -13%
SB
3
Samsara BioCapital
California
$4.26M 3,640,015
PHS
4
PFM Health Sciences
California
$2.74M 2,341,107
Marshall Wace
5
Marshall Wace
United Kingdom
$2.46M 2,105,262
Morgan Stanley
6
Morgan Stanley
New York
$2.31M 1,972,343 -224,891 -10%
Bank of America
7
Bank of America
North Carolina
$1.93M 1,651,515 -192,670 -10%
AC
8
Armistice Capital
New York
$1.81M 1,545,000 -179,000 -10%
PBPIA
9
Pivotal bioVenture Partners Investment Advisor
California
$1.01M 864,197
LGM
10
Logos Global Management
California
$578K 493,827
Fidelity Investments
11
Fidelity Investments
Massachusetts
$368K 314,600
SCM
12
Soleus Capital Management
Connecticut
$225K 192,670 +192,670 New
Renaissance Technologies
13
Renaissance Technologies
New York
$212K 180,800 +13,600 +8%
BCM
14
Bridgeway Capital Management
Texas
$146K 124,623
Citadel Advisors
15
Citadel Advisors
Florida
$102K 86,894 +28,272 +48%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$39K 33,307
XT
17
XTX Topco
Cayman Islands
$31.1K 26,555 +10,688 +67%
RWMG
18
Redwood Wealth Management Group
New Jersey
$4.87K 4,166 +4,166 New
UBS Group
19
UBS Group
Switzerland
$3.84K 3,280 +3,280 New
SCM
20
Stonepine Capital Management
Oregon
-156,167 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
Alyeska Investment Group
22
Alyeska Investment Group
Illinois